Lindhofer competitive analysis

Loading summary...

Explore Lindhofer's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer10

Latest publications and patents of Lindhofer New

Explore the latest publications and patents granted to Lindhofer, showcasing their recent innovations and technological advancements.

Last updated on: Oct 17, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Lindhofer

Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerRevoked

Latest PTAB cases involving Lindhofer

Discover the latest PTAB cases involving Lindhofer, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lindhofer with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LINDHOFER - 10 - -
ABBVIE109 - 1
BOEHRINGER INGELHEIM RCV BOEHRINGER INGELHEIM7 - - -
DR H ULRICH DORRIES26 - - -